More Data Needed for Neoadjuvant Tx for Bile Duct Cancer More Data Needed for Neoadjuvant Tx for Bile Duct Cancer
In a debate held recently on the use of neoadjuvant therapy for high-risk intrahepatic cholangiocarcinoma, both sides agreed that more research is needed.Medscape Medical News
Source: Medscape General Surgery Headlines - Category: Surgery Tags: Hematology-Oncology News Source Type: news
More News: Bile | Bile Duct Cancer | Cancer | Cancer & Oncology | Cholangiocarcinoma | Hematology | Neoadjuvant Therapy | Surgery